(Q44022846)

29 November 2017

title

Synthesis of substituted diarylmethylenepiperidines (DAMPs), a novel class of anti-HIV agents (English)

1 reference

29 November 2017

9

Yves Pommier

1 reference

29 November 2017

Guozhang Xu

1

1 reference

29 November 2017

Arunachalam Kannan

2

1 reference

29 November 2017

Tracy L Hartman

3

1 reference

29 November 2017

Heather Wargo

4

1 reference

29 November 2017

Karen Watson

5

1 reference

29 November 2017

Jim A Turpin

6

1 reference

29 November 2017

Robert W Buckheit

7

1 reference

29 November 2017

Allison A Johnson

8

1 reference

29 November 2017

Mark Cushman

10

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Bioorganic & Medicinal Chemistry

29 November 2017

published in

1 reference

29 November 2017

volume

10

1 reference

29 November 2017

issue

8

1 reference

29 November 2017

page(s)

2807-2816

1 reference

Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society-USA Panel

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Antiretroviral therapy for patients with HIV disease

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Chemotherapeutic agents for human immunodeficiency virus infection: mechanism of action, pharmacokinetics, metabolism, and adverse reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Design, synthesis, and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease and integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Synthesis of a cosalane analog with an extended polyanionic pharmacophore conferring enhanced potency as an anti-HIV agent

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Exploration of the effects of linker chain modifications on anti-HIV activities in a series of cosalane analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Correlation of anti-HIV potency with lipophilicity in a series of cosalane analogs having normal alkenyl and phosphodiester chains as cholestane replacements

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Synthesis and Anti-HIV Activity of Cosalane Analogues with Substituted Benzoic Acid Rings Attached to the Pharmacophore through Methylene and Amide Linkers

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Synthesis and biological evaluation of certain alkenyldiarylmethanes as anti-HIV-1 agents which act as non-nucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Synthesis of a non-nucleoside reverse transcriptase inhibitor in the alkenyldiarylmethane (ADAM) series with optimized potency and therapeutic index

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Novel modifications in the alkenyldiarylmethane (ADAM) series of non-nucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Inhibition of acute-, latent-, and chronic-phase human immunodeficiency virus type 1 (HIV-1) replication by a bistriazoloacridone analog that selectively inhibits HIV-1 transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Potent and specific inhibition of HIV envelope-mediated cell fusion and virus binding by G quartet-forming oligonucleotide (ISIS 5320).

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Structure-activity and cross-resistance evaluations of a series of human immunodeficiency virus type-1-specific compounds related to oxathiin carboxanilide

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

Comparative anti-HIV evaluation of diverse HIV-1-specific reverse transcriptase inhibitor-resistant virus isolates demonstrates the existence of distinct phenotypic subgroups

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

In vitro human immunodeficiency virus type 1 integrase assays

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900095-0

7 January 2021

10.1016/S0968-0896(02)00095-0

Identifiers

DOI

1 reference

29 November 2017

1 reference